Focus on Cancer

is one usually met with utter dread.

The Scientist Staff
Apr 10, 2005
<p></p>

The diagnosis of cancer is one usually met with utter dread. At the same time, science is moving quickly to identify, differentiate, and treat tumors – which ones will metastasize, which ones will respond to particular treatments, and which ones are likely to remain harmless in people who die of old age.

Those efforts are the focus of this special feature in The Scientist. On the next several pages, you'll hear from Yale professor of pharmacology and biotech company founder Joseph Schlessinger. Schlessinger recounts the 25 years of his and his colleagues' work to discover and develop SU11248, a receptor tyrosine kinase inhibitor being used in clinical trials to treat patients with gastrointestinal stromal tumors and chronic myelogenous leukemia.

Our Hot Papers are two studies that described gene expression profiles and molecular signatures of lung adenocarcinoma and other solid tumors. Next, Arul Chinnaiyan, a professor of pathology at...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?